H1
Healthcare intelligence, precisely sourced
New York, NY, US
H1 is a health data platform for therapeutic development.
How We Help
Problem Statement
Healthcare information is fragmented and inaccessible, making it difficult to find critical expertise, healthcare professional (HCP) information, claims data, and research.
Core Technology
Data Aggregation & Analytics
Key Differentiators
Provides a comprehensive global directory of healthcare professionals and organizations.; Compiles data from public, private, and proprietary sources.
Clinical Focus
Medical Affairs; Clinical Operations; Drug Development
Company Info
- Business Model
- SaaS
- Total Funding
- 251,000,000
- Website
- h1.co
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Former FDA Commissioner Dr. Stephen M. Hahn joined board in 2025. 2024 Fierce Award for Excellence in Data-Driven Diversity Practices. Trial Landscape platform helps companies comply with FDA diversity requirements in clinical trials. AI-powered site selection identifies 25% more qualified trial sites.
MedStartr Index Score
?What do you think of H1?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.